Cover Image
市場調查報告書

全球寵物醫療市場:各產品(疫苗,寄生蟲驅除劑,抗發炎藥,醫療用食品添加物,其他的醫藥品),診斷技術,動物(狗,貓,馬),地區 - 趨勢及預測

Global Companion Animal Health Market - Growth, Trends and Forecasts (2017 - 2022)

出版商 Mordor Intelligence LLP 商品編碼 319394
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球寵物醫療市場:各產品(疫苗,寄生蟲驅除劑,抗發炎藥,醫療用食品添加物,其他的醫藥品),診斷技術,動物(狗,貓,馬),地區 - 趨勢及預測 Global Companion Animal Health Market - Growth, Trends and Forecasts (2017 - 2022)
出版日期: 2017年01月24日 內容資訊: 英文 190 Pages
簡介

全球寵物醫療市場在2013年為85億美元規模。一般認為該市場今後將以年複合成長率7.86%持續成長,到2019年將達到133億7,000萬美元的規模。

本報告提供全球寵物醫療市場現況與未來預測,提供您各市場區隔,各地區趨勢,並彙整主要的參與企業競爭環境與簡介等資料。

第1章 簡介

第2章 市場分析

  • 動物醫療產品
  • 動物醫療和人的醫療

第3章 市場趨勢

  • 推動市場的要素
    • 寵物飼主感情
    • 營養的改善
    • 消費者對食品安全性的注意力提升
    • 飼料的增產
    • 動物平原性傳染病及透過食物傳染的疾病
  • 阻礙市場的要素
    • 耕地和水的危機
    • 耕地的競爭激烈
    • 成本效益高的生產
  • 波特五力分析

第4章 市場區隔

  • 各產品
    • 寄生蟲驅除劑
    • 抗發炎藥
    • 醫療用食品添加物
    • 其他的醫藥品
    • 疫苗
  • 寵物

第5章 全球寵物診斷藥市場

  • 酵素連結免疫吸附法(ELISA)
  • Rapid Immuno Migration( RIM)
  • Agar gel Immuno Diffusion( AGID)

第6章 全球寵物遺傳學市場

第7章 各地區市場市場區隔

  • 北美
  • 歐洲
  • 亞太地區

第8章 競爭環境

  • 市場上主要企業
  • 合併·收購
  • 新產品上市
  • 協定,聯合,夥伴關係
  • 其他

第9章 企業簡介

  • Zoetis animal healthcare
  • Merck
  • Merial
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第10章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Description

The global market for companion animal healthcare is valued at $9.16 billion in 2013. Expected to grow at a CAGR of 7.86%, the market is set to reach $13.37 billion by 2020.

The companion animal health market is segmented based on type of products i. e Vaccines, Paraciticides, Anti-infectives, Medicinal feed additives, and other pharmaceuticals, based on diagnostics i.e Enzyme Linked Immuno sorbent assay(ELISA), Rapid Immuno Migration( RIM), based on genetics,based on geography market is divided into North America, Asia-Pacific, Europe and Rest of World. Europe accounts for the largest share of the animal vaccines market, followed by North America. The developing regions like Asia-pacific and Africa are expected to form a new revenue pocket in the market. Countries such as India, China, Brazil will be the major contributors in the market.

Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France) are the key players in the global companion animal health market

What makes our report unique?

1) In depth analysis of current market trends and future forecasts of the market based on different products available for both companion animals and farm animals

2) We provide longest possible market segmentation of the market based on products available, diagnostics, genetics , and geography. We give you the competitive landscape for the market which provides information about major players in the market, Market Share and recent developments.

3) High level analysis on products i.e Vaccines, anti-infectants, MFA, Paraciticides andintroduced novel vaccines such as DNA and recombinant vaccines.

Table of Contents

1.INTRODUCTION

  • 1.1 Market Definition
  • 1.2 Market Recent Trends

2. Market Analysis

  • 2.1 Market Animal Health Products
  • 2.2 Animal medicines vs human Medicines

3. Market Dynamics

  • 3.1 Market Drivers
    • 3.1.1 Increase in pet ownership
    • 3.1.2 Improved Nutrition
    • 3.1.3 Intensifying consumer focus on food safety
    • 3.1.4 Greater Livestock production
    • 3.1.5 Increasing Zoonotic and Foodborne Diseases
  • 3.2 Market Constraints
    • 3.2.1 Scarcity of arable land and water
    • 3.2.2 Increased competition for cultivated land
    • 3.2.3 Cost effective production
  • 3.3 Porter's Five Force Analysis
    • 3.3.1 Threat of New Entrant
    • 3.3.2 Internal Rivalry
    • 3.3.3 Buyer bargaining power
    • 3.3.4 Supplier bargaining power
    • 3.3.5 Threat of substitutes

4.Market Segmentation

  • 4.1 Global Companion Animal Market Segmentation- By products
    • 4.1.1 Paraciticides
    • 4.1.2 Anti-Infectives
    • 4.1.3 Medicinal Feed Additives
    • 4.1.4 Other Pharmaceuticals
    • 4.1.5 Vaccines
  • 4.2 .Companion Animals
    • 4.2.1 Dogs
    • 4.2.2 Cats
    • 4.2.3 Horses

5. Global Companion Animal Diagnostics Market

  • 5.1 Enzyme Linked Immuno Sorbent Assay( ELISA)

5. 2 Rapid Immuno Migration( RIM)

5. 3 Agar gel Immuno Diffusion( AGID)

6. Global Companion Animal Genetics Market

  • 6.1 HD 50K for Angus
  • 6.2 CLARIFIDE for Dairy
  • 6.3 Sheep 50K
  • 6.4 CLARIFIDE for Nelore
  • 6.5 Others

7. Global Companion Market Segmentation, By Geography

  • 7.1 North America
    • 7.1.1 US
    • 7.1.2 Mexico
    • 7.1.3 Canada
  • 7.2 Europe
    • 7.2.1 France
    • 7. 2.2 Italy
    • 7.2.3 Germany
    • 7.2.4 Spain
    • 7.2.5 UK
  • 7.3 Asia-Pacific
    • 7.3.1 India
    • 7.3.2 China
    • 7.3.3 Japan
    • 7.3.4 Rest of Asia-Pacific

8. Competitive landscape

  • 8.1 Major players in the market
  • 8.2 mergers and acquisitions
  • 8.3 New product launches
  • 8.4 Agreement, Collaborations and Partnerships
  • 8.5 Recommendations for new players in the market
  • 8.6 Recommendations for existing players in the market
  • 8.7 Market Share Analysis

9. Company Profiles

  • 9.1 Zoetis animal healthcare
    • 9.1.1 Financial Overview
    • 9.1.2 Business overview
    • 9.1.3 Business strategies
  • 9.2 Merck
    • 9.2.1 Financial Overview
    • 9.2.2Business overview
    • 9.2.3 Business strategies
  • 9.3 Merial (Animal Health Division Of Sanofi)
    • 9.3.1 Financial Overview
    • 9.3.2 Business overview
    • 9.3.3 Business strategies
  • 9.4 Elanco
    • 9.4.1 Financial Overview
    • 9.4.2 Business overview
    • 9.4.3 Business strategies
  • 9.5 Bayer healthcare
    • 9.5.1 Financial Overview
    • 9.5.2 Business overview
    • 9.5.3 Business strategies
  • 9.6 Novartis Animal Health, Inc.
    • 9.6.1 Financial Overview
    • 9.6.2 Business overview
    • 9.6.3. Business strategies
  • 9.7 Virbac
    • 9.7.1 Financial Overview
    • 9.7.2 Business overview
    • 9.7.3 Business strategies
  • 9.8 Boehringer Ingelheim
    • 9.8.1 Financial Overview
    • 9.8.2 Business overview
    • 9.8.3 Business strategies

10. Appendix

  • 10.1.Abbreviations
  • 10.2.Sources
  • 10.3.Bibliography
  • 10.4.Disclaimer
Back to Top